Re-Vana Therapeutics is a ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.
United Kingdom:
T: +44 (0) 28 9097 5814
E: info@re-vana.com
USA:
T: +1 (813) 323 1438
E: mor.revana@gmail.com
Mailing:
McClay Research Centre
97 Lisburn Road
Belfast, BT9 7BL
United Kingdom
Re-Vana Therapeutics Inc.
1027 South Dakota Ave
Tampa, FL 33606
USA